Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Biohaven Ltd (NYSE: BHVN) was $13.74 for the day, down -2.97% from the previous closing price of $14.16. In other words, the price has decreased by -$2.97 from its previous closing price. On the day, 2.05 million shares were traded. BHVN stock price reached its highest trading level at $14.31 during the session, while it also had its lowest trading level at $13.71.
Ratios:
Our analysis of BHVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.82. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Citigroup on September 17, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On September 03, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $75.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on May 19, 2025, while the target price for the stock was maintained at $21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.
CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share. On Oct 02 ’24, another insider, CHILDS JOHN W, who serves as the Director of the company, bought 21,052 shares for $47.50 each. As a result, the insider paid 999,970 and bolstered with 21,052 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1453568256 and an Enterprise Value of 1083042816.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.45, which has changed by -0.7315358 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $55.70, while it has fallen to a 52-week low of $12.79. The 50-Day Moving Average of the stock is -6.04%, while the 200-Day Moving Average is calculated to be -42.70%.
Shares Statistics:
BHVN traded an average of 2.14M shares per day over the past three months and 2811340 shares per day over the past ten days. A total of 105.78M shares are outstanding, with a floating share count of 92.38M. Insiders hold about 12.68% of the company’s shares, while institutions hold 82.81% stake in the company. Shares short for BHVN as of 1756425600 were 10645888 with a Short Ratio of 4.98, compared to 1753920000 on 12714495. Therefore, it implies a Short% of Shares Outstanding of 10645888 and a Short% of Float of 11.3199994.
Earnings Estimates
As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$1.47, with high estimates of -$1.15 and low estimates of -$1.81.
Analysts are recommending an EPS of between -$5.94 and -$6.87 for the fiscal current year, implying an average EPS of -$6.37. EPS for the following year is -$5.39, with 6.0 analysts recommending between -$4.69 and -$6.29.
Revenue Estimates
Based on 17 analysts’ estimates, the company’s revenue will be $101.36M in the next fiscal year. The high estimate is $215.28M and the low estimate is $14.44M.
